The artificial kidney market size has grown rapidly in recent years. It will grow from $9.22 billion in 2023 to $10.48 billion in 2024 at a compound annual growth rate (CAGR) of 13.7%. The growth in the historic period can be attributed to the increased prevalence of chronic kidney diseases (CKD), limited availability of donor organs, advancements in renal replacement therapies, improving the quality of life for end-stage renal disease (ESRD) patients, and the rise in the aging population.
The artificial kidney market size is expected to see rapid growth in the next few years. It will grow to $16.74 billion in 2028 at a compound annual growth rate (CAGR) of 12.4%. The growth in the forecast period can be attributed to rising healthcare investments and initiatives, patient preference for home-based therapies, and global efforts to reduce dialysis dependency. Major trends in the forecast period include the integration of sensors and monitoring devices, telehealth integration, focus on biocompatibility and immunogenicity, regulatory framework development, and global collaborations and research consortia.
The escalation in chronic kidney conditions is anticipated to drive the expansion of the artificial kidney sector in the forthcoming period. Chronic kidney disease, characterized by a gradual decline in kidney function, necessitates treatments such as artificial kidneys. These devices facilitate the elimination of waste products and toxins from the body, aiding in fluid retention and maintaining electrolyte balance. As reported by Kidney Research UK in June 2023, an estimated 7.19 million individuals in the UK were affected by chronic kidney disease, surpassing 10% of the population, with projections expecting a rise to 7.61 million by 2033. Consequently, the rising prevalence of chronic kidney diseases is a pivotal factor propelling growth in the artificial kidney market.
The burgeoning demand for kidney transplants is poised to propel the advancement of the artificial kidney industry. Kidney transplants involve the surgical implantation of a healthy donor kidney into an individual whose own kidneys are failing. Artificial kidneys, serving as interim solutions, offer a promising alternative while awaiting a suitable donor for a traditional transplant. This transition could substantially enhance the quality of life for recipients and alleviate the burdens of undergoing dialysis. According to the Health Resources and Services Administration in 2021, the count of adults awaiting kidney transplants surged by 11.6%, rising from 37,399 in 2020 to 41,765 in 2021. Hence, the escalating demand for kidney transplants is a driving force behind the growth of the artificial kidney market.
Technological advancements represent a prominent trend surging within the artificial kidney sector. Key market players are actively introducing cutting-edge products to fortify their market stance. An illustration of this trend is observed in NephroPlus' Renova, launched in July 2022. This innovative dialyzer reprocessing system, equipped with cloud storage, stands as a testament to such progress. Renova, a cloud-connected device, empowers biomedical engineers to troubleshoot issues remotely, utilizing cloud-based connectivity. Through the Renova app, engineers gain access to real-time status updates, including detailed operations analysis, facilitating precise diagnostics and swift resolutions. The dialyzer, integral to this system, plays a pivotal role in mitigating infection risks, enhancing dialysis quality, and proficiently purging toxins from the blood, compensating for the kidneys' diminished function.
Major entities within the artificial kidney sphere are heavily invested in crafting innovative solutions, notably portable hemodialysis devices. An exemplar in this realm is Nextkidney's Neokidney, announced in November 2022. This portable hemodialysis device, compact and user-friendly, redefines accessibility by enabling patients to undergo dialysis in the comfort of their homes or any location with electricity. The Neokidney's operational efficiency, requiring merely 7 liters of water per treatment, significantly mitigates logistical complexities and wastage. Facilitating more frequent and shorter-duration dialysis sessions, this device holds promise in potentially ameliorating overall health outcomes for patients.
In April 2023, M42, a tech-enabled healthcare company based in the United Arab Emirates, successfully acquired Diaverum for an undisclosed sum from Bridgepoint. This strategic acquisition positions M42 to extend its footprint in the healthcare sector, introduce innovative solutions to a global patient base, and leverage Diaverum's extensive network of clinics and patients specializing in dialysis services.
Major companies operating in the artificial kidney market report are Fresenius SE And Co. KGaA, Medtronic Plc., Asahi Kasei Medical Co. Ltd., Toray Industries Inc., Baxter International Inc., DaVita Inc., B. Braun Melsungen AG, UCLA Health, Revvity, Nipro Medical Corporation, Nikkiso Co. Ltd., Merit Medical Systems Inc., Kawasumi Laboratories Inc., Quanta Dialysis Technologies Ltd., Triomed AB, Advent Access, WearOptimo, AWAK Technologies Pvt. Ltd., Aethlon Medical Inc., Blood Purification Technologies Inc., Xcorporeal Inc., Nanodialysis B.V, Neokidney Development BV, Wearable Medical Devices Inc., Nephria Bio Inc., US Kidney Research Corporation.
North America was the largest region in the artificial kidney market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial kidney market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the artificial kidney market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The primary categories of artificial kidneys include wearable artificial kidneys and implantable artificial kidneys. Wearable artificial kidneys are portable devices worn by patients to simulate the functions of a natural kidney. This category encompasses methods such as hemodialysis, peritoneal dialysis, and combination approaches. The main end-users of artificial kidneys include hospitals, specialty clinics, ambulatory surgical centers, and other medical facilities.
The artificial kidney market research report is one of a series of new reports that provides artificial kidney market statistics, including artificial kidney industry global market size, regional shares, competitors with an artificial kidney market share, detailed artificial kidney market segments, market trends and opportunities, and any further data you may need to thrive in the artificial kidney industry. This artificial kidney market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The artificial kidney market consists of sales of peritoneal dialysis systems, hemodialysis artificial kidneys, dialysis membranes, filtration systems, pumping systems, bioartificial kidneys, dialysate compartments, and semipermeable hollow fibers. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
The artificial kidney market size is expected to see rapid growth in the next few years. It will grow to $16.74 billion in 2028 at a compound annual growth rate (CAGR) of 12.4%. The growth in the forecast period can be attributed to rising healthcare investments and initiatives, patient preference for home-based therapies, and global efforts to reduce dialysis dependency. Major trends in the forecast period include the integration of sensors and monitoring devices, telehealth integration, focus on biocompatibility and immunogenicity, regulatory framework development, and global collaborations and research consortia.
The escalation in chronic kidney conditions is anticipated to drive the expansion of the artificial kidney sector in the forthcoming period. Chronic kidney disease, characterized by a gradual decline in kidney function, necessitates treatments such as artificial kidneys. These devices facilitate the elimination of waste products and toxins from the body, aiding in fluid retention and maintaining electrolyte balance. As reported by Kidney Research UK in June 2023, an estimated 7.19 million individuals in the UK were affected by chronic kidney disease, surpassing 10% of the population, with projections expecting a rise to 7.61 million by 2033. Consequently, the rising prevalence of chronic kidney diseases is a pivotal factor propelling growth in the artificial kidney market.
The burgeoning demand for kidney transplants is poised to propel the advancement of the artificial kidney industry. Kidney transplants involve the surgical implantation of a healthy donor kidney into an individual whose own kidneys are failing. Artificial kidneys, serving as interim solutions, offer a promising alternative while awaiting a suitable donor for a traditional transplant. This transition could substantially enhance the quality of life for recipients and alleviate the burdens of undergoing dialysis. According to the Health Resources and Services Administration in 2021, the count of adults awaiting kidney transplants surged by 11.6%, rising from 37,399 in 2020 to 41,765 in 2021. Hence, the escalating demand for kidney transplants is a driving force behind the growth of the artificial kidney market.
Technological advancements represent a prominent trend surging within the artificial kidney sector. Key market players are actively introducing cutting-edge products to fortify their market stance. An illustration of this trend is observed in NephroPlus' Renova, launched in July 2022. This innovative dialyzer reprocessing system, equipped with cloud storage, stands as a testament to such progress. Renova, a cloud-connected device, empowers biomedical engineers to troubleshoot issues remotely, utilizing cloud-based connectivity. Through the Renova app, engineers gain access to real-time status updates, including detailed operations analysis, facilitating precise diagnostics and swift resolutions. The dialyzer, integral to this system, plays a pivotal role in mitigating infection risks, enhancing dialysis quality, and proficiently purging toxins from the blood, compensating for the kidneys' diminished function.
Major entities within the artificial kidney sphere are heavily invested in crafting innovative solutions, notably portable hemodialysis devices. An exemplar in this realm is Nextkidney's Neokidney, announced in November 2022. This portable hemodialysis device, compact and user-friendly, redefines accessibility by enabling patients to undergo dialysis in the comfort of their homes or any location with electricity. The Neokidney's operational efficiency, requiring merely 7 liters of water per treatment, significantly mitigates logistical complexities and wastage. Facilitating more frequent and shorter-duration dialysis sessions, this device holds promise in potentially ameliorating overall health outcomes for patients.
In April 2023, M42, a tech-enabled healthcare company based in the United Arab Emirates, successfully acquired Diaverum for an undisclosed sum from Bridgepoint. This strategic acquisition positions M42 to extend its footprint in the healthcare sector, introduce innovative solutions to a global patient base, and leverage Diaverum's extensive network of clinics and patients specializing in dialysis services.
Major companies operating in the artificial kidney market report are Fresenius SE And Co. KGaA, Medtronic Plc., Asahi Kasei Medical Co. Ltd., Toray Industries Inc., Baxter International Inc., DaVita Inc., B. Braun Melsungen AG, UCLA Health, Revvity, Nipro Medical Corporation, Nikkiso Co. Ltd., Merit Medical Systems Inc., Kawasumi Laboratories Inc., Quanta Dialysis Technologies Ltd., Triomed AB, Advent Access, WearOptimo, AWAK Technologies Pvt. Ltd., Aethlon Medical Inc., Blood Purification Technologies Inc., Xcorporeal Inc., Nanodialysis B.V, Neokidney Development BV, Wearable Medical Devices Inc., Nephria Bio Inc., US Kidney Research Corporation.
North America was the largest region in the artificial kidney market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial kidney market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the artificial kidney market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The primary categories of artificial kidneys include wearable artificial kidneys and implantable artificial kidneys. Wearable artificial kidneys are portable devices worn by patients to simulate the functions of a natural kidney. This category encompasses methods such as hemodialysis, peritoneal dialysis, and combination approaches. The main end-users of artificial kidneys include hospitals, specialty clinics, ambulatory surgical centers, and other medical facilities.
The artificial kidney market research report is one of a series of new reports that provides artificial kidney market statistics, including artificial kidney industry global market size, regional shares, competitors with an artificial kidney market share, detailed artificial kidney market segments, market trends and opportunities, and any further data you may need to thrive in the artificial kidney industry. This artificial kidney market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The artificial kidney market consists of sales of peritoneal dialysis systems, hemodialysis artificial kidneys, dialysis membranes, filtration systems, pumping systems, bioartificial kidneys, dialysate compartments, and semipermeable hollow fibers. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Table of Contents
1. Executive Summary2. Artificial Kidney Market Characteristics3. Artificial Kidney Market Trends and Strategies32. Global Artificial Kidney Market Competitive Benchmarking33. Global Artificial Kidney Market Competitive Dashboard34. Key Mergers and Acquisitions in the Artificial Kidney Market
4. Artificial Kidney Market - Macro Economic Scenario
5. Global Artificial Kidney Market Size and Growth
6. Artificial Kidney Market Segmentation
7. Artificial Kidney Market Regional and Country Analysis
8. Asia-Pacific Artificial Kidney Market
9. China Artificial Kidney Market
10. India Artificial Kidney Market
11. Japan Artificial Kidney Market
12. Australia Artificial Kidney Market
13. Indonesia Artificial Kidney Market
14. South Korea Artificial Kidney Market
15. Western Europe Artificial Kidney Market
16. UK Artificial Kidney Market
17. Germany Artificial Kidney Market
18. France Artificial Kidney Market
19. Italy Artificial Kidney Market
20. Spain Artificial Kidney Market
21. Eastern Europe Artificial Kidney Market
22. Russia Artificial Kidney Market
23. North America Artificial Kidney Market
24. USA Artificial Kidney Market
25. Canada Artificial Kidney Market
26. South America Artificial Kidney Market
27. Brazil Artificial Kidney Market
28. Middle East Artificial Kidney Market
29. Africa Artificial Kidney Market
30. Artificial Kidney Market Competitive Landscape and Company Profiles
31. Artificial Kidney Market Other Major and Innovative Companies
35. Artificial Kidney Market Future Outlook and Potential Analysis
36. Appendix
Executive Summary
Artificial Kidney Global Market Report 2024 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on artificial kidney market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
- Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
- Assess the Russia-Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
- Measure the impact of high global inflation on market growth.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis.
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for artificial kidney? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? This report answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.
- The impact of higher inflation in many countries and the resulting spike in interest rates.
- The continued but declining impact of COVID-19 on supply chains and consumption patterns.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Report Scope
Markets Covered:1) By Product Type: Wearable Artificial Kidney; Implantable Artificial Kidney
2) By Dialysis: Hemodialysis; Peritoneal Dialysis; Combination
3) By End-user: Hospitals; Specialty Clinics; Ambulatory Surgical Centers; Other End-user
Key Companies Mentioned: Fresenius SE and Co. KGaA; Medtronic Plc.; Asahi Kasei Medical Co. Ltd.; Toray Industries Inc.; Baxter International Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes
Delivery Format: PDF, Word and Excel Data Dashboard
Companies Mentioned
- Fresenius SE And Co. KGaA
- Medtronic Plc.
- Asahi Kasei Medical Co. Ltd.
- Toray Industries Inc.
- Baxter International Inc.
- DaVita Inc.
- B. Braun Melsungen AG
- UCLA Health
- Revvity
- Nipro Medical Corporation
- Nikkiso Co. Ltd.
- Merit Medical Systems Inc.
- Kawasumi Laboratories Inc.
- Quanta Dialysis Technologies Ltd.
- Triomed AB
- Advent Access
- WearOptimo
- AWAK Technologies Pvt. Ltd.
- Aethlon Medical Inc.
- Blood Purification Technologies Inc.
- Xcorporeal Inc.
- Nanodialysis B.V
- Neokidney Development BV
- Wearable Medical Devices Inc.
- Nephria Bio Inc.
- US Kidney Research Corporation
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 175 |
| Published | February 2024 |
| Forecast Period | 2024 - 2028 |
| Estimated Market Value ( USD | $ 10.48 Billion |
| Forecasted Market Value ( USD | $ 16.74 Billion |
| Compound Annual Growth Rate | 12.4% |
| Regions Covered | Global |
| No. of Companies Mentioned | 26 |
